Oncology & Hematology Coding Alert
Add Q2023 to Medicare Payable List
But check the status indicator for this July 1 code. • Q2023 -- Injection, factor VIII (antihemophilic factor, recombinant) (Xyntha), per i.u. Xyntha temporarily raises factor VIII levels in the blood to aid clotting for patients with hemophilia. The codes' coverage indicator is "E," which means, "Excluded from physician fee schedule by regulation." Codes with status "E" don't have RVUs, but when they're covered, the carrier/contractor pays them under reasonable charge procedures. Transmittal 1752, released June 5, which announces the change, indicates Q2023 is payable for services on or after July 1 (www.cms.hhs.gov/Transmittals/downloads/R1752CP.pdf).
Oncology & Hematology Coding Alert
- Prevent HCPCS Mistakes From Chipping Away at CHOP Reimbursement
Here's why you shouldn't report every drug in the regimen. An oncologist may prescribe a [...] - News You Can Use:
Catch This 77421 Supervision Switch, and Free the MD's Time
A fee schedule update offers a spot of physician supervision clarity. You can mark one [...] - You Be the Coder:
Determine Proper Treatment Device Coding
Question: If the patient requires both a mask (complex) and a bite block (intermediate), may [...] - Do Admit Codes and Admission Have to Show Same DOS?
Overlook this rule, and risk leaving rightful E/M dollars on the table. When the oncologist [...] - To Do:
Add Q2023 to Medicare Payable List
But check the status indicator for this July 1 code. Medicare's July 2009 HCPCS update [...] - Reader Questions:
Record Reason for Lengthy Infusion Time
Question: The oncologist ordered a 90-minute chemotherapy infusion service, but the infusion lasted a few [...] - Reader Questions:
Watch These Oral Emend Requirements
Question: We've been getting conflicting information on reporting oral Emend for patients when our office [...] - Reader Questions:
Report HDR per Treatment
Question: Should we code HDR and its components once or twice each day if we [...] - Reader Questions:
Sort Through LCDs for Rituximab Coverage
Question: Is thrombotic thrombocytopenic purpura a covered diagnosis for Rituximab infusions? Idaho Subscriber Answer: The [...]
